🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Seli Sikiilii › New York

Qorannoo klinikaalii Dhibee Seli Sikiilii New York keessatti

Qorannoo 21 Dhibee Seli Sikiilii f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Mount Sinai Hospital, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07187973

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Childrens Hospital at Montefiore, The Bronx
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Columbia University Medical Center_New York_0, New York
  • Columbia University Medical Center_New York_0, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • NYC Health+Hospitals, Brooklyn
  • Interfaith Medical Center, Brooklyn
  • Cohen Children's Medical Ctr, Queens
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Icahn School of Medicine at Mount Sinai, New York
  • Jacobi Medical Center, The Bronx
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Western New York BloodCare, Buffalo
  • Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
  • Weill Cornell Medical College - New York Presbyterian Hospital, New York
  • fi 2 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Mount Sinai Medical Center, New York
  • Jacobi Medical Center, The Bronx
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Jacobi Medical Center, The Bronx
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07224360

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • Richmond University Medical Center- Site Number : 8400038, Staten Island
  • Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06975865

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

  • New York Medical College, Valhalla
Namoota walitti qabaa jiraSadarkaa 2
6 Months – 21 Years · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT02675959

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering, New York
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 50 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT04819841

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

  • Columbia University Irving Medical Center, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 50 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT07015684

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Roswell Park (MRD-HCT), Buffalo
  • Columbia Presbytarian (NT-DMT), New York
  • Cohen's Children Hospital (NT-DMT), Queens
  • fi 4 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 20 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06941389

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

  • Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
  • Memorial Sloan Kettering Westchester (Consent only), Harrison
  • Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 50 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05736419

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 35 · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT05477563

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Columbia University, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT03587272

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Columbia University Irving Medical Center, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 14 hanga 37 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07373639

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Weil Cornell Medical College, New York
  • University of Rochester Medical Center, Rochester
Namoota walitti qabaa jira
Umuriin 16 hanga 30 · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06374238

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

  • Mount Sinai Hospital, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2025 · NCT05519111

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

  • New York Medical College, Valhalla
Namoota walitti qabaa jiraSadarkaa 2
1 Day – 30 Years · Saalaa hunda · Haaromfame 08-Hag-2025 · NCT04099966

Cannabidiol in Sickle Cell Disease

  • Icahn School of Medicine at Mount Sinai, Manhattan
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT06930703

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.